Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

3SBio Inc. M&A Activity 2016

Dec 28, 2016

49981_rns_2016-12-28_05f78336-da62-4b1d-ad18-ec5d692ed21e.pdf

M&A Activity

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this joint announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this joint announcement.

==> picture [75 x 34] intentionally omitted <==

LIPPO LIMITED 力 寶 有 限 公 司

(Incorporated in Hong Kong with limited liability) (Stock Code: 226)

HONGKONG CHINESE LIMITED * 香 港 華 人 有 限 公 司

(Incorporated in Bermuda with limited liability) (Stock Code: 655)

JOINT ANNOUNCEMENT

MAJOR AND CONNECTED TRANSACTION

SUPPLEMENTAL AGREEMENTS RELATING TO THE DISPOSAL OF ADDITIONAL 31% INTERESTS IN THE MACAU CHINESE BANK LIMITED

Reference is made to the joint announcement issued by Lippo Limited (“ Lippo ”) and Hongkong Chinese Limited (“ HKC ”) dated 28th October, 2015 in respect of the Sale and Purchase Agreements relating to the Second Disposal (the “ Joint Announcement ”). Capitalised terms used in this joint announcement shall have the same meanings as those defined in the Joint Announcement, unless the context otherwise requires.

On 28th December, 2016 (after the trading hours of the Stock Exchange), the Vendor, being a wholly-owned subsidiary of HKC which in turn is an indirect subsidiary of Lippo, and the Purchasers, entered into supplemental agreements to the Sale and Purchase Agreements in relation to the Second Disposal, to extend the date for obtaining the approval of AMCM from 31st December, 2016 to 30th June, 2017. Save and except for the aforementioned amendment, all the other terms and conditions of the Sale and Purchase Agreements shall remain unchanged and continue in full force and effect.

By Order of the Board LIPPO LIMITED John Luen Wai Lee Managing Director and Chief Executive Officer

By Order of the Board HONGKONG CHINESE LIMITED John Luen Wai Lee Chief Executive Officer

Hong Kong, 28th December, 2016

  • 1 -

As at the date of this joint announcement, the board composition of each of Lippo and HKC is as follows:

Lippo

Executive Directors:

Dr. Stephen Riady (Chairman) Mr. John Luen Wai Lee (Managing Director and Chief Executive Officer)

HKC

Executive Directors: Dr. Stephen Riady (Chairman) Mr. John Luen Wai Lee (Chief Executive Officer)

Non-executive Directors: Mr. Jark Pui Lee Mr. Leon Nim Leung Chan

Non-executive Director: Mr. Leon Nim Leung Chan

Independent Non-executive Directors: Mr. Edwin Neo Mr. Victor Ha Kuk Yung Mr. King Fai Tsui

Independent Non-executive Directors: Mr. Albert Saychuan Cheok Mr. Victor Ha Kuk Yung Mr. King Fai Tsui

*For identification purpose only

  • 2 -